Coexisting Purpuric and Pseudo-Chilblain Lesions in COVID-19 Patients.

Tammaro, Antonella; Alexander, Shehani; Adebanjo, Ganiyat Adenike Ralitsa; Parisella, Francesca Romana; Rello, Jordi; Ramirez-Estrada, Sergio

Tammaro, Antonella; Alexander, Shehani; Adebanjo, Ganiyat Adenike Ralitsa; Parisella, Francesca Romana; Rello, Jordi; Ramirez-Estrada, Sergio.

Tammaro A; Dermatology Department, NESMOS, Sapienza University of Rome, Rome, Italy; antonella.tammaro@uniroma1.it.
Alexander S; Dermatology Department, NESMOS, Sapienza University of Rome, Rome, Italy.
Adebanjo GAR; Dermatology Department, NESMOS, Sapienza University of Rome, Rome, Italy.
Parisella FR; Department of Medicine, University of Queensland, Brisbane, Australia.
Rello J; Critical Care Department, Clínica Corachan, Barcelona, Spain.
Ramirez-Estrada S; Centro de Investigación Biomedica en Red de Enfermedades Respirorias (CIBERES), Instituto Salud Carlos III, Madrid, Spain.

Skinmed ; 20(2): 155-158, 2022.

Article in English | MEDLINE | ID: covidwho-1824477

Subject(s)

COVID-19; Chilblains; Dermatitis; Purpura; COVID-19/complications; Chilblains/diagnosis; Chilblains/pathology; Humans; Purpura/diagnosis; Purpura/etiology; SARS-CoV-2

Search on Google

XML

PubMed Links

Collection: International databases Database: MEDLINE Main subject: Purpura / Chilblains / Dermatitis / COVID-19 Type of study: Diagnostic study Topics: Long Covid Limits: Humans Language: English Journal: Skinmed Journal subject: Dermatology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

PubMed Links